Placenta
Volume 29, Issue 2 , Pages 148-157 , February 2008

Impaired Placentation in Fetal Alcohol Syndrome

  • F. Gundogan

      Affiliations

    • Departments of Pathology and Medicine, Women and Infants Hospital, Providence, RI 02903, USA
    • The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • G. Elwood

      Affiliations

    • Rhode Island Hospital, Providence, RI 02903, USA
    • ,
  • L. Longato

      Affiliations

    • Rhode Island Hospital, Providence, RI 02903, USA
    • ,
  • M. Tong

      Affiliations

    • Rhode Island Hospital, Providence, RI 02903, USA
    • The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • A. Feijoo

      Affiliations

    • Rhode Island Hospital, Providence, RI 02903, USA
    • ,
  • R.I. Carlson

      Affiliations

    • Rhode Island Hospital, Providence, RI 02903, USA
    • ,
  • J.R. Wands

      Affiliations

    • Rhode Island Hospital, Providence, RI 02903, USA
    • The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA
    • ,
  • S.M. de la Monte

      Affiliations

    • Departments of Pathology and Medicine, Women and Infants Hospital, Providence, RI 02903, USA
    • Rhode Island Hospital, Providence, RI 02903, USA
    • The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA
    • Corresponding Author InformationCorresponding author: Pierre Galletti Research Building, Rhode Island Hospital, 55 Claverick Street, Room 419, Providence, RI 02903, USA. Tel.: +1 401 444 7364; fax: +1 401 444 2939.

,Accepted 10 October 2007.

References 

  1. Barr HM, Streissguth AP. Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2001;25(2):283–287
  2. de la Monte SM, Xu XJ, Wands JR. Ethanol inhibits insulin expression and actions in the developing brain. Cell Mol Life Sci. 2005;62(10):1131–1145
  3. Soscia SJ, Tong M, Xu XJ, Cohen AC, Chu J, Wands JR, et al. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci. 2006;63(17):2039–2056
  4. O'Leary CM. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. J Paediatr Child Health. 2004;40(1-2):2–7
  5. Cornelius MD, Goldshmidt L, Taylor PM, Day NL. Prenatal alcohol use among teenagers: effects on neonatal outcomes. Alcohol Clin Exp Res. 1999;23(7):1238–1244
  6. Bada HS, Das A, Bauer CR, Shankaran S, Lester BM, Gard CC, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005;25(10):631–637
  7. Kaminski M, Rumeau C, Schwartz D. Alcohol consumption in pregnant women and the outcome of pregnancy. Alcohol Clin Exp Res. 1978;2(2):155–163
  8. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990;345(6270):78–80
  9. Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 2005;146(3):1498–1505
  10. Han VK, Carter AM. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta. 2000;21(4):289–305
  11. Jia S, VanDusen WJ, Diehl RE, Kohl NE, Dixon RA, Elliston KO, et al. cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. J Biol Chem. 1992;267(20):14322–14327
  12. Christiansen JH, Coles EG, Wilkinson DG. Molecular control of neural crest formation, migration and differentiation. Curr Opin Cell Biol. 2000;12(6):719–724
  13. Cotter D, Honavar M, Lovestone S, Raymond L, Kerwin R, Anderton B, et al. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol (Berl). 1999;98(5):465–472
  14. Small D, Kovalenko D, Kacer D, Liaw L, Landriscina M, Di Serio C, et al. Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype. J Biol Chem. 2001;276(34):32022–32030
  15. Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, et al. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest. 1996;98(6):1313–1323
  16. Ince N, de la Monte SM, Wands JR. Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res. 2000;60(5):1261–1266
  17. de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, et al. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol. 2006;44(5):971–983
  18. Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR, et al. Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest. 2002;82(7):881–891
  19. Maeda T, Sepe P, Lahousse S, Tamaki S, Enjoji M, Wands JR, et al. Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells. J Hepatol. 2003;38(5):615–622
  20. Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, et al. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 2006;44(2):446–457
  21. Gundogan F, Elwood G, Greco D, Rubin LP, Pinar H, Carlson RI, et al. Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: relevance to early pregnancy loss. Hum Pathol. 2007;38(1):50–59
  22. Xu J, Yeon JE, Chang H, Tison G, Chen GJ, Wands J, et al. Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase. J Biol Chem. 2003;278(29):26929–26937
  23. Urso T, Gavaler JS, Van Thiel DH. Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci. 1981;28(9):1053–1056
  24. Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, et al. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev. 2004;28(5):313–318
  25. Yeon JE, Califano S, Xu J, Wands JR, de La Monte SM. Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology. 2003;38(3):703–714
  26. Takahashi H, Ozturk M, Wilson B, Maki A, Ozawa K, Koizumi M, et al. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma. Hepatology. 1989;9(4):625–634
  27. Wilson B, Ozturk M, Takahashi H, Motte P, Kew M, Isselbacher KJ, et al. Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype. Proc Natl Acad Sci U S A. 1988;85(9):3140–3144
  28. Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, et al. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev. 2000;16(6):434–441
  29. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16(1):3–34
  30. Naeye RL. Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol. 1989;20(5):441–444
  31. Banerjee K, Mohr L, Wands JR, de la Monte SM. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells. Alcohol Clin Exp Res. 1998;22(9):2093–2101
  32. de la Monte SM, Ganju N, Tanaka S, Banerjee K, Karl PJ, Brown NV, et al. Differential effects of ethanol on insulin-signaling through the insulin receptor substrate-1. Alcohol Clin Exp Res. 1999;23(5):770–777
  33. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early-pregnancy origins of low birth weight. Nature. 2002;417(6892):916
  34. Crossey PA, Pillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest. 2002;110(3):411–418
  35. Han VK, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab. 1996;81(7):2680–2693
  36. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab. 2001;86(8):3665–3674
  37. Shin JC, Lee JH, Yang DE, Moon HB, Rha JG, Kim SP. Expression of insulin-like growth factor-II and insulin-like growth factor binding protein-1 in the placental basal plate from pre-eclamptic pregnancies. Int J Gynaecol Obstet. 2003;81(3):273–280
  38. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 1991;98(7):648–655

☆ Supported by AA-02666, AA-02169, AA-11431, AA-12908, AA-16126 and K08AA016783 from the National Institutes of Health.

PII: S0143-4004(07)00251-2

doi: 10.1016/j.placenta.2007.10.002

Placenta
Volume 29, Issue 2 , Pages 148-157 , February 2008

Article Tools

* Image Usage & Resolution